| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |